Browse the complete record of transactions filed by Cherevka Holli, Chief Executive Officer. Director active across 1 companies, notably Ampio Pharmaceuticals, Inc.. Cumulatively, 8 disclosures have been published. The latest transaction was filed on 1 January 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Holli Cherevka is the Chief Operating Officer and President at Ampio Pharmaceuticals, Inc. She leads the company's operations, ensuring that strategic objectives are met. Holli brings extensive experience in the pharmaceutical sector, contributing to innovation and growth at Ampio. Her leadership is essential for the company's future.